PDT

JDD February 2023 Issue Highlights
171321713217132The February issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and brief communications exploring topics such as efficacy and safety of 1% clascoterone cream in patients aged ≥12 years with acne vulgaris, dupilumab’s impact on atopic dermatitis among adolescent and adult patients, development and validation of a photonumeric scale …
The Burden of Long-Standing UV-Radiation Exposure: Treatment Options for AKs and NMSC
147831478314783Actinic Keratoses (AKs)The numbers are staggering when it comes to the management of skin cancer in the United States and worldwide. Signs of chronic exposure to ultraviolet (UV) rays from the sun and/or indoor tanning bed use include solar lentigines, hyperpigmentation, wrinkles and pre-cancerous lesions called actinic keratoses. Actinic Keratoses (AKs) best identified as scaly, pink macules and papules, result from lo …
Actinic Keratoses (AKs)
Actinic Keratoses: Evidence-Based Treatment Options
126891268912689Actinic KeratosesDr. Hanke, a dermatologic surgeon who needs no introduction (but I’ll give one anyway!) provided us with an evidence-based discussion of field treatments available for actinic keratoses at ODAC 2021 conference. Just to name a few of Dr. Hanke’s accomplishments, he is the current Senior Vice President of the Skin Cancer Foundation, Senior editor of JDD, and the former president of the AAD, A …
Actinic Keratoses
Does This Skin Cancer Really Need Mohs?
100971009710097Have you ever come across a patient with a skin cancer that you are not 100% sure should be treated with Mohs surgery or an alternative modality? Or a patient who comes back for a follow-up after skin cancer surgery with an undesirable scar and you wonder if you should have opted for a less invasive option? I certainly have. Some of these nagging questions were answered by a thoughtful, case-based …